Ikarian Capital, LLC I Teos Therapeutics, Inc. Transaction History
Ikarian Capital, LLC
- $606 Million
- Q4 2024
A detailed history of Ikarian Capital, LLC transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Ikarian Capital, LLC holds 78,585 shares of ITOS stock, worth $496,657. This represents 0.1% of its overall portfolio holdings.
Number of Shares
78,585
Previous 78,574
0.01%
Holding current value
$496,657
Previous $802,000
24.81%
% of portfolio
0.1%
Previous 0.14%
Shares
4 transactions
Others Institutions Holding ITOS
# of Institutions
149Shares Held
33.3MCall Options Held
454KPut Options Held
2.45M-
Black Rock Inc. New York, NY3.73MShares$23.6 Million0.0% of portfolio
-
Mpm Asset Management LLC Cambridge, MA2.74MShares$17.3 Million16.91% of portfolio
-
Bvf Inc San Francisco, CA2.33MShares$14.7 Million0.67% of portfolio
-
Ra Capital Management, L.P. Boston, MA2.09MShares$13.2 Million0.26% of portfolio
-
Jpmorgan Chase & CO New York, NY2.07MShares$13.1 Million0.0% of portfolio
About iTeos Therapeutics, Inc.
- Ticker ITOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,575,300
- Market Cap $225M
- Description
- Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...